DK
Therapeutic Areas
Certa Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| FT011 (asengeprast) | Systemic sclerosis (scleroderma) | Phase 2 |
| FT012 | Chronic kidney disease | Preclinical |
| FT013 | Diabetic nephropathy | Preclinical |
| FT014 | Focal segmental glomerulosclerosis | Preclinical |